Product Manager, US Patient Marketing - EMPAVELI

Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. Summary: Biogen Rare Disease is seeking a passionate and talented marketer for the role of Product Manager, US Patient Marketing - EMPAVELI This is an opportunity to make a significant impact for patients living with paroxysmal nocturnal hemoglobinuria (PNH) and for the business by executing the US patient marketing plan for EMPAVELI (pegcetacoplan), the first C3 inhibitor approved for PNH. The Product Manager owns day-to-day execution of the US PNH patient and caregiver marketing plan (approximately 75% of the role) and serves as the digital content lead for patient marketing across the rare disease franchise, PNH and nephrology (C3G/IC-MPGN) (approximately 25% of the role). The role translates brand strategy into patient-facing content, programs, and field/patient-services resources; manages agency partners from brief through PRC approval to launch; and partners with the Omnichannel team, which owns campaign execution, audience segmentation, media orchestration, website builds and releases, and the martech stack. This role owns what the brand says and the programs behind it; Omnichannel owns how it gets delivered. This role requires cross-functional leadership across Patient Services, Advocacy, Medical, Legal/Regulatory/PRC, Privacy, Analytics, and Field teams. This role reports to the US Hematology Marketing Lead, with a dotted line to US Nephrology Patient Marketing Lead. Roles and Responsibilities: Hematology Patient Marketing (~75%): Execute the US PNH patient marketing plan for EMPAVELI, branded and unbranded, in line with the brand strategy set by the US Hematology Marketing Lead; manage agency partners in the execution of that plan Lead patient and caregiver content strategy and orchestration: patient brochures and print education, patient website updates (branded and unbranded), patient stories and videos, social content, and the patient podcasts (episode creative and per-episode social feedback with the podcast vendor) Partner with Patient Services, Advocacy, and Corporate Communications on PNH patient program planning and promotion, including the PNH Patient Summit, Ambassador program, Meet-a-Peer, and event registration and follow-up; own the patient field team handoffs Develop patient-facing resources and enablement for Patient Access Managers, ACEs, and sales, including NSM/POA patient sessions, in partnership with Training and Field Leadership Generate and apply patient insights (advisory boards, market research, competitive insights) and translate them into messaging and tactics Define and track the patient marketing KPI plan; recommend courses of action based on results Administer the patient marketing budget efficiently and thoughtfully (SOWs, POs, accruals) Work closely with Regulatory, Legal, Compliance, and Privacy on patient-facing policies and procedures, including consent and data capture for patient forms and programs Digital Content & Omnichannel Partnership - Hematology and Nephrology (~25%): Serve as digital content lead for patient marketing across PNH and nephrology (C3G/IC-MPGN): content strategy and orchestration, creative briefs, brand-connected assets, CRM/email, banners, paid and organic social, online video, and website content, with creative direction from brief through PRC approval to handoff with creative agencies Act as the brand-side counterpart to the Omnichannel team: hand off approved assets, align segment-specific and sequential messaging to brand objectives, and ensure digital drivers ladder to patient program and website goals Own PNH field digital enablement: NPI leads handoff and post-handoff feedback loop with the field, the monthly field team cadence, and RTE templates for Patient Access Managers and Account Managers Own measurement beyond media for PNH: email, RTE/CVA, congress, leads, and podcast reporting, in partnership with Analytics; bring insights into the monthly performance cadence Support nephrology patient digital content, including influencer program assets, landing pages, and online video, in partnership with the US Nephrology Patient Marketing Lead Maintain working knowledge of the martech and compliance stack (Veeva, Salesforce Marketing Cloud, patient data platform, cookie consent) to brief work correctly and flag privacy/consent requirements early Support 2027+ brand planning on digital innovation, including vendor sourcing, vetting, and onboarding and AI-enabled tools Education, Registration & Certification: Bachelor's degree required MBA or other advanced degree is a plus Experience: 3+ years of biotech/pharma marketing experience, with direct experience in patient/DTC marketing Experience developing digital content (email/CRM, web, social, video) through MLR/PRC review is required; Veeva PromoMats experience preferred Experience in rare disease and/or hematology is preferred; experience with an in-market brand with a label update or new-indication expansion is a plus Experience working alongside omnichannel, media, and analytics teams, and managing multiple agency partners, is a plus Experience in patient services, field, or customer-facing roles is a plus Skills, Knowledge & Abilities: Passion for understanding and championing the needs of people living with rare diseases and their caregivers, translating them into market-moving insights Proficiency with high-science data and a demonstrated ability to convert it into compliant, patient-friendly messaging Working fluency in digital content development and performance metrics, with the judgment to know what the brand should say and how to brief it so Omnichannel can execute Ability to navigate and be successful in a fast-paced, results-driven environment, managing through ambiguity Commitment to collaboration and engagement, with a history of success leading in a matrix environment and with agency partners An entrepreneurial spirit coupled with the drive to embrace innovation and develop creative but well-reasoned solutions to business challenges Motivation to build the patient programs, content, and processes that sustain a growing in-market brand Demonstrated integrity on the job, including an understanding of relevant rules and regulations (promotional compliance, PRC/MLR, patient privacy and consent) Strong communication skills with the ability to influence across functions and varying levels of the organization Willing to travel domestically up to 30% of the time and attend events outside of business hours (e.g., occasional weekends and evenings)

#LI-SL1

Benefits and Perks: health insurance with full premium coverage 401K with company match paid time off (PTO) long- term disability insurance life insurance Company Background: We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases. Visit to learn more. EEO Statement: Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumocononiosis or any other characteristic protected under applicable federal, state or local law. Other Duties: Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice. Travel Requirements: Willing to travel domestically up to 30% of the time and attend events outside of business hours (e.g., occasional weekends and evenings). Education: Bachelor's Degree Pay Information: Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies. The targeted base salary range for this position is $117,000-$157,000. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions. Work Arrangement: Hybrid Benefits and Perks: a 401(k) plan with company match inclusive family building benefits flexible time off summer and winter shutdowns paid family leave disability and life insurance Special Note on Biogen Acquisition Please note that as of May 14th, Biogen Inc. has acquired Apellis Pharmaceuticals. Click here to learn more about Benefits & Perks of working at Biogen: Benefits | Biogen Company Background: Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit or follow us on LinkedIn and X. #J-18808-Ljbffr Apellis Pharmaceuticals, Inc.